1型糖尿病患者的肠道菌群特征及血浆代谢物:按白蛋白尿分层分析
这项横断面研究纳入161例长病程1型糖尿病患者和50名健康对照,按既往白蛋白尿水平分为正常白蛋白尿、微量白蛋白尿和大量白蛋白尿三组。研究发现,1型糖尿病患者肠道菌群和血浆代谢物谱异常,且不同白蛋白尿水平的患者呈现不同的菌群和代谢物特征,提示肠道菌群与糖尿病肾病早期阶段相关。
要点
- 长病程1型糖尿病患者存在肠道菌群和血浆代谢物谱异常。
- 伴微量或大量白蛋白尿的1型糖尿病患者肠道菌群β多样性与健康对照显著不同。
- 大量白蛋白尿患者血浆吲哚硫酸盐、L-瓜氨酸等代谢物水平较正常或微量白蛋白尿患者升高。
核心结论
- 长病程1型糖尿病患者肠道菌群和血浆代谢物谱异常,且不同白蛋白尿水平的患者菌群和代谢物特征不同。
研究设计与样本
- 横断面研究纳入161例长病程1型糖尿病患者和50名健康对照,按既往白蛋白尿水平将患者分为正常白蛋白尿(<3.39 mg/mmol)、微量白蛋白尿(3.39-33.79 mg/mmol)和大量白蛋白尿(≥33.90 mg/mmol)三组。
主要发现
- 1型糖尿病患者与健康对照相比,324个菌属中有79个相对丰度存在差异,31种血浆代谢物中有11种存在显著差异。
- 大量白蛋白尿患者血浆吲哚硫酸盐和L-瓜氨酸浓度高于正常或微量白蛋白尿患者。
- 大量白蛋白尿患者血浆同型瓜氨酸和L-犬尿氨酸水平高于正常白蛋白尿患者。
- 大量白蛋白尿患者血浆色氨酸浓度低于正常白蛋白尿患者。
临床怎么用
- 对长病程1型糖尿病患者,可关注肠道菌群和血浆代谢物谱变化,尤其是白蛋白尿进展者。
- 血浆吲哚硫酸盐、L-瓜氨酸、同型瓜氨酸、L-犬尿氨酸和色氨酸等代谢物可能与白蛋白尿水平相关。
局限性
- 横断面设计无法推断因果关系。
- 白蛋白尿分组基于历史测量,可能存在分类偏差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Abnormal gut microbiota and blood metabolome profiles have been reported both in children and adults with uncomplicated type 1 diabetes as well as in adults with type 1 diabetes and advanced stages of diabetic nephropathy. In this study we aimed to investigate the gut microbiota and a panel of targeted plasma metabolites in individuals with type 1 diabetes of long duration without and with different levels of albuminuria. METHODS: In a cross-sectional study we included 161 individuals with type 1 diabetes and 50 healthy control individuals. Individuals with type 1 diabetes were categorised into three groups according to historically measured albuminuria: (1) normoalbuminuria (<3.39 mg/mmol); (2) microalbuminuria (3.39-33.79 mg/mmol); and (3) macroalbuminuria (≥33.90 mg/mmol). From faecal samples, the gut microbiota composition at genus level was characterised by 16S rRNA gene amplicon sequencing and in plasma a targeted profile of 31 metabolites was analysed with ultra HPLC coupled to MS/MS. RESULTS: Study participants were aged 60 ± 11 years (mean ± SD) and 42% were women. The individuals with type 1 diabetes had had diabetes for a mean of 42 ± 15 years and had an eGFR of 75 ± 25 ml min-1 (1.73 m)-2. Measures of the gut microbial beta diversity differed significantly between healthy controls and individuals with type 1 diabetes, either with micro- or macroalbuminuria. Taxonomic analyses showed that 79 of 324 genera differed in relative abundance between individuals with type 1 diabetes and healthy controls and ten genera differed significantly among the three albuminuria groups with type 1 diabetes. For the measured plasma metabolites, 11 of 31 metabolites differed significantly between individuals with type 1 diabetes and healthy controls. When individuals with type 1 diabetes were stratified by the level of albuminuria, individuals with macroalbuminuria had higher plasma concentrations of indoxyl sulphate and L-citrulline than those with normo- or microalbuminuria and higher plasma levels of homocitrulline and L-kynurenine compared with individuals with normoalbuminuria. Whereas plasma concentrations of tryptophan were lower in individuals with macroalbuminuria compared with those with normoalbuminuria. CONCLUSIONS/INTERPRETATION: We demonstrate that individuals with type 1 diabetes of long duration are characterised by aberrant profiles of gut microbiota and plasma metabolites. Moreover, individuals with type 1 diabetes with initial stages of diabetic nephropathy show different gut microbiota and plasma metabolite profiles depending on the level of albuminuria. Graphical abstract.
引用
- Winther SA, Henriksen P, Vogt JK, et al. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria. Diabetologia. 2020. PMID: 32886190. doi:10.1007/s00125-020-05260-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。